top of page |
Details of the target gene |
Gene Model of Rodent Parasite |
PBANKA_0403200
|
Gene Model P. falciparum ortholog |
PF3D7_0304600
|
Gene product | circumsporozoite (CS) protein |
Gene product: Alternative name | CSP |
top of page |
Details of the genetic modification |
Short description of the mutation | The P. berghei csp gene replaced by P. falciparum csp |
Inducable system used | No |
Short description of the conditional mutagenesis | Not available |
Additional remarks inducable system |
|
Type of plasmid/construct | (Linear) plasmid double cross-over |
PlasmoGEM (Sanger) construct/vector used | No |
Modified PlasmoGEM construct/vector used | No
|
Plasmid/construct map |
|
Plasmid/construct sequence |
|
Restriction sites to linearize plasmid |
|
Selectable marker used to select the mutant parasite | not available |
Promoter of the selectable marker | not available |
Selection (positive) procedure | pyrimethamine |
Selection (negative) procedure | No |
Additional remarks genetic modification | A P. berghei transgenic parasite was generated expressing the full-length P. falciparum CS protein (3D7). In this transgenic line, a single amino acid in the CS protein region containing the sequence DYANDIEKKI was modified to incorporate the cytotoxic CD8+ T cell epitope DYENDIEKKI. This epitope is not found in the 3D7 strain, but is present in other P. falciparum isolates (such as 7G8 and T4). The full-length PfCS with the P. berghei native signal sequence was cloned into the CS locus of GFP-luciferase P. berghei ANKA.
To develop the chimeric line P.b.-P.f. CSP-FL CD8CT, a 784-bp restriction fragment encompassing base pairs 246 to 1029 of the P. berghei-P. falciparum CSP NT csp chimeric gene was excised from the plasmid pIC-CSPPfNT (37) using restriction enzymes BbsI and PacI (New England Biolabs). This portion was replaced with a 943-bp fragment, which was released using the same restriction enzymes as for the pHZ-PfCSP plasmid. The csp gene (1188 bp) in the resulting plasmid, pIC-CSPfFL-CD8CT, consists of a full-length P. falciparum 3D7 CSP in which the signal sequence was replaced with that from the P. berghei CSP (base pairs 1 to 69). In addition, a single base pair in the plasmid pIC-CSPfFL-CD8CT CS gene was replaced to incorporate a cytotoxic epitope not present in the P. falciparum 3D7 strain. This change was introduced in base pair 1079 by site-directed mutagenesis using the QuikChange II XL Site-Directed Mutagenesis Kit (Agilent Technologies). We then excised the CS gene from pIC-CSPfFL-CD8CT as a KpnI-PacI fragment and inserted it into the transfection plasmid pR-CSPfFL-CD8CT. XhoI and KasI were used to linearize pR-CSPfFL-CD8CT prior to transfection of GFP-luciferase P. berghei ANKA parasites.
reference 37:
Espinosa DA, Gutierrez GM, Rojas-López M, Noe AR, Shi L, Tse S-W, Sinnis P, Zavala F. 2015.
Proteolytic Cleavage of the Plasmodium falciparum Circumsporozoite Protein Is a Target of
Protective Antibodies. The Journal of infectious diseases 212:1111-1119. |
Additional remarks selection procedure | |
Primer information: Primers used for amplification of the target sequences
Primer information: Primers used for amplification of the target sequences
Sequence Primer 1 | |
Additional information primer 1 | |
Sequence Primer 2 | |
Additional information primer 2 | |
Sequence Primer 3 | |
Additional information primer 3 | |
Sequence Primer 4 | |
Additional information primer 4 | |
Sequence Primer 5 | |
Additional information primer 5 | |
Sequence Primer 6 | |
Additional information primer 6 | |
|
|
top of page |